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 Editorial  Divestment or management?  Organisational ethics and commercial sponsorship.    This edition of the Australasian Epidemiologists’ roundtable asks the question whether the AEA should accept sponsorship for conferences and events from commercial organizations?  There has been concern expressed in the academic literature, by the public, and by some individuals and professions about the extent to which the activities of professional associations are or can be influenced by corporate funding.1    These concerns raise important questions about the ethics of organizations recognizing that “moral demands exist not only on the individual but also on organizations, systems and institutions.”2 The field of organizational ethics provides a framework to enable organizations to evaluate whether the organization’s practices are consistent with its professed values.3  A professional association represents the values of its members and is a public face of a profession.  Accordingly, this raises a question for an organization about how it can model best practices for its members and how it can maintain the trust of the public in the profession.  As Brody notes “Trust is a delicate matter that often depends as much on appearance as on reality.”4  The AEA states that one of its aims is to develop “strategic alliances with related organisations to maintain high standards of public health practice, teaching and research in Australasia”.5 If the “maintenance of high standards of 
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public health practice” is a central organizational value for the AEA then it is important to examine whether the receipt of sponsorship from commercial organisations has any potential to give rise to a perception that the organisation might put aside its primary interest to further its sponsor’s interests and in so doing compromise the trust vested in the organization and the profession by society.6   It is not a given that both parties to a sponsorship transaction are motivated by the public good; a commercial organisation’s primary motivation is generally to sell a product or a service to further the private good of its shareholders and a professional association’s is to make recommendations on public health related issues based on evidence.7    As Brody notes, there are essentially two possible approaches to the question of whether to accept industry sponsorship.8 The first is a divestment strategy where no sponsorship is accepted from commercial organizations, generally so as to maintain the public’s perception that the association is a trustworthy source of information.  The second is a management strategy where sponsorship may be accepted under certain conditions; conditions designed to limit the degree of influence the commercial organization has on the professional association’s functions and to maintain the integrity of the organization.  There are a variety of strategies suggested as to how best to do this, but many focus on disclosure.  The challenge is that some evidence suggests that, as Kirkland notes, “neither awareness nor disclosure is adequate to negate the potential influences of relationships between individuals with conflicting interests”.9    Parkin and Paul start off the discussion by arguing for a divestment strategy – that the AEA should not under any circumstances accept pharmaceutical industry sponsorship for scientific meetings and other events.  Parkin and Paul focus on the risks to the AEA’s integrity from receiving industry sponsorship.  They argue that the refusal of sponsorship from pharmaceutical and vaccine companies is critical to maintaining and enhancing the 
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reputation of the AEA as an advocate for robust scientific practices and for beneficial public health policies and argue that accepting funding may compromise AEA’s independence.  Drawing on his experience as President of the International Society for Behavioral Nutrition and Physical Activity, Crawford argues that professional associations should carefully consider the benefits and costs of accepting industry sponsorship, highlighting the important of perceptions of independence when professional associations advocate for particular issues.  The remaining authors argue for a management strategy: that the AEA should continue to accept conference related sponsorship from commercial companies if certain conditions are met and certain rules abided by.  Accordingly, in the third Roundtable paper Raynes-Greenow suggests that there is an important difference between industry funding of research and industry funding of conferences.  The former creates conflicts of interest shown to distort the results of such research.  The latter, she argues, creates potential conflicts of interest that are manageable by conference organizers through the usual structures of conferences and the institution of certain practices, including disclosure, not accepting sponsorship from certain types of sponsors, seeking multiple sponsors, and maintaining standards for the organization of conferences.  Le Jian also argues that sponsorship can be accepted as long as the AEA considers whether the products or services that the company produces broadly align with the AEA’s public health related mission.  Naggan suggests that the reality is that commercial sponsorship funds much research.  Such research must be disseminated and this may be supported by commercial organizations as long as independence is preserved.  Diug advocates the development of guidelines in respect of the relationship between professional organization’s and commercial sponsors. This roundtable discussion has illustrated some of the issues that arise in the context of determining whether the AEA should accept any form of sponsorship from commercial organizations.  It has also illustrated a variety of opinions on whether the AEA should adopt a divestment strategy (i.e. accept no sponsorship) or whether it should adopt a management strategy and what the components of that strategy should be.  An organizational ethics perspective would suggest that it is important that the AEA clarify how its values, mission and objectives may be affected by commercial sponsorship and 
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develop a policy to address this issue to provide clarity and certainly to its members, to the public and other interested stakeholders, and to potential sponsors.        
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